The oral iron chelator deferasirox inhibits NF-kappa B mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia
Ashish Banerjee, Nicole A Mifsud, Robert Bird, Cecily Forsyth, Jeff Szer, Constantine Tam, Sybil Kellner, Andrew Grigg, Penelope Motum, Mark Bentley, Stephen Opat, George Grigoriadis
British Journal of Haematology | WILEY-BLACKWELL | Published : 2015
This study was carried out using funds provided by Novartis, which had no say in the study design or interpretation of results. GG is supported by a Victorian cancer agency clinical research fellowship.